For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
Sildenafil Citrate RS and Sildenafil N-Oxide USP System Suitability Solution on Luna Omega 5 µm C18 150x4.6mm LC/UV
26200
Separation Mode: Reversed Phase
Reversed Phase
USP
C18
HPLC
Pharmaceutical/Biopharmaceutical
Pharmaceutical
Therapeutic / Clinical

Sildenafil Citrate RS and Sildenafil N-Oxide USP System Suitability Solution on Luna Omega 5 µm C18 150x4.6mm LC/UV

Analytes
1Sildenafil citrate
2Sildenafil N-Oxide
Details
Official Method: USP
LC Conditions (App ID: 26200)
Column:
Brand Name:
Luna Omega
Part No:
Phase Name:
C18
System:
Agilent Technologies 1100 Series Agilent Technologies 1100 Series
Sample Note:
Dissolve 70 mg of Sildenafil Citrate in 1 mL of a solution of hydrogen peroxide and anhydrous formic acid (2:1). Allow to stand for at least 10 minutes to generate Sildenafil N-Oxide, then dilute w/mobile phase to 250 mL.
Similar Applications
search
No Data